Результати пошуку - Erin Macrae

  • Показ 1 - 8 результатів із 8
Уточнити результати
  1. 1
    Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer

    Role of trastuzumab emtansine in the treatment of HER2-positive breast cancer за авторством Drew Oostra, Erin Macrae

    Опубліковано 2014
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  2. 2
    Use and Duration of Chemotherapy in Patients With Metastatic Breast Cancer According to Tumor Subtype and Line of Therapy

    Use and Duration of Chemotherapy in Patients With Metastatic Breast Cancer According to Tumor Subtype and Line of Therapy за авторством Davinia Seah, Inês Vaz-Luís, Erin Macrae, Jessica Sohl, Georgia Litsas, Eric P. Winer, Nancy U. Lin, Harold J. Burstein

    Опубліковано 2014
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  3. 3
    Neoadjuvant Dual HER2-Targeted Therapy With Lapatinib and Trastuzumab Improves Pathologic Complete Response in Patients With Early Stage HER2-Positive Breast Cancer: A Meta-Analysis of Randomized Prospective Clinical Trials

    Neoadjuvant Dual HER2-Targeted Therapy With Lapatinib and Trastuzumab Improves Pathologic Complete Response in Patients With Early Stage HER2-Positive Breast Cancer: A Meta-Analysi... за авторством Mellissa Hicks, Erin Macrae, Mahmoud Abdel‐Rasoul, Rachel M. Layman, Susan Friedman, Jenny Querry, Maryam B. Lustberg, Bhuvaneswari Ramaswamy, Ewa Mrózek, Charles L. Shapiro, Robert Wesolowski

    Опубліковано 2015
    Отримати повний текст Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  4. 4
    Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Update

    Endocrine Treatment and Targeted Therapy for Hormone Receptor–Positive, Human Epidermal Growth Factor Receptor 2–Negative Metastatic Breast Cancer: ASCO Guideline Update за авторством Harold J. Burstein, Mark R. Somerfield, Debra L. Barton, Ali Dorris, Lesley Fallowfield, Dharamvir Jain, Stephen Johnston, Larissa A. Korde, Jennifer K. Litton, Erin Macrae, Lindsay L. Peterson, Praveen Vikas, Rachel L. Yung, Hope S. Rugo

    Опубліковано 2021
    Отримати повний текст
    Revisão
    Додати у Вибране
    Збережено в:
  5. 5
    Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline

    Endocrine Therapy for Hormone Receptor–Positive Metastatic Breast Cancer: American Society of Clinical Oncology Guideline за авторством Hope S. Rugo, R. Bryan Rumble, Erin Macrae, Debra L. Barton, Hannah Connolly, Maura N. Dickler, Lesley Fallowfield, Barbara Fowble, James N. Ingle, Mohammad Jahanzeb, Stephen Johnston, Larissa A. Korde, James Khatcheressian, Rita S. Mehta, Hyman B. Muss, Harold J. Burstein

    Опубліковано 2016
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  6. 6
    Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients

    Heterogeneous atypical cell populations are present in blood of metastatic breast cancer patients за авторством Maryam B. Lustberg, Priya Balasubramanian, Brandon Miller, Alejandra Garcia-Villa, Clayton Deighan, Yongqi Wu, Sarah Carothers, Michael Berger, Bhuvaneswari Ramaswamy, Erin Macrae, Robert Wesolowski, Rachel M. Layman, Ewa Mrózek, Xueliang Pan, Thomas A. Summers, Charles L. Shapiro, Jeffrey J. Chalmers

    Опубліковано 2014
    Отримати повний текст Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  7. 7
    Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer

    Circulating myeloid-derived suppressor cells increase in patients undergoing neo-adjuvant chemotherapy for breast cancer за авторством Robert Wesolowski, Megan Duggan, Andrew Stiff, Joseph Markowitz, Prashant Trikha, Kala Levine, Lynn Schoenfield, Mahmoud Abdel‐Rasoul, Rachel M. Layman, Bhuvaneswari Ramaswamy, Erin Macrae, Maryam B. Lustberg, Raquel E. Reinbolt, Ewa Mrózek, John C. Byrd, Michael A. Caligiuri, Thomas A. Mace, William E. Carson

    Опубліковано 2017
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:
  8. 8
    Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF<sup>V600E</sup></i> Mutations: Results of the NCI-MATCH Trial Subprotocol H

    Dabrafenib and Trametinib in Patients With Tumors With <i>BRAF<sup>V600E</sup></i> Mutations: Results of the NCI-MATCH Trial Subprotocol H за авторством April K.S. Salama, Shuli Li, Erin Macrae, Jong–In Park, Edith P. Mitchell, James A. Zwiebel, Helen X. Chen, Robert J. Gray, Lisa M. McShane, Larry Rubinstein, David R. Patton, P. Mickey Williams, Stanley R. Hamilton, Deborah K. Armstrong, Barbara A. Conley, Carlos L. Arteaga, Lyndsay N. Harris, Peter J. O’Dwyer, Alice P. Chen, Keith T. Flaherty

    Опубліковано 2020
    Отримати повний текст
    Artigo
    Додати у Вибране
    Збережено в:

Інструменти для пошуку: